Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway

Biochemical and Biophysical Research Communications

Volumn 396, Issue 2, 2010, Pages 562-565

  Lyo, Donggon ^a   Xu, Limei ^a   Foster, David A ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

HDM2; mTOR; Phospholipase D; Serum and glucocorticoid induced kinase 1

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHOLIPASE D; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN MDM2; SERUM AND GLUCOCORTICOID REGULATED KINASE 1;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SIGNAL TRANSDUCTION;

CELL LINE, TUMOR; ENZYME STABILITY; HUMANS; IMMEDIATE-EARLY PROTEINS; KIDNEY NEOPLASMS; PHOSPHATIDIC ACIDS; PHOSPHOLIPASE D; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MDM2; TRANSCRIPTION FACTORS; UBIQUITIN-PROTEIN LIGASES;

MAMMALIA;

EID: 77952745635     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.148     Document Type: Article

References (40)

1. Donaldson J.G. Phospholipase D in endocytosis and endosomal recycling pathways. Biochim. Biophys. Acta 1791 (2009) 845-849
2. Foster D.A. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochem. Biophys. Acta 1791 (2009) 949-955
3. Lee C.S., Kim K.L., Jang J.H., Choi Y.S., Suh P.G., and Ryu S.H. The roles of phospholipase D in EGFR signaling. Biochim. Biophys. Acta 1791 (2009) 862-868
4. Sun Y., and Chen J. mTOR signaling: PLD takes center stage. Cell Cycle 7 (2008) 3118-3123
5. Guertin D.A., and Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 12 (2007) 9-22
6. Sancak Y., Peterson T.R., Shaul Y.D., Lindquist R.A., Thoreen C.C., Bar-Peled L., and Sabatini D.M. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320 (2008) 1496-1501
7. Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A., Vasquez D.S., Turk B.E., and Shaw R.J. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30 (2008) 214-226
8. Inoki K., Ouyang H., Zhu T., Lindvall C., Wang Y., Zhang X., Yang Q., Bennett C., Harada Y., Stankunas K., Wang C.Y., He X., MacDougald O.A., You M., Williams B.O., and Guan K.L. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126 (2006) 955-968
9. Manning B.D., and Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 129 (2007) 1261-1274
10. Kim D.H., Sarbassov D.D., Ali S.M., King J.E., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110 (2002) 163-175
11. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., Tempst P., and Sabatini D.M. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14 (2004) 1296-1302
12. Sabatini D.M. mTOR and cancer: insights into a complex relationship. Nat. Rev. Cancer 6 (2006) 729-734
13. Sarbassov D.D., Ali S.M., Sengupta S., Sheen J.H., Hsu P.P., Bagley A.F., Markhard A.L., and Sabatini D.M. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Mol. Cell 22 (2006) 159-168
14. Toschi A., Lee E., Xu L., Garcia A., Gadir N., and Foster D.A. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Mol. Cell. Biol. 29 (2009) 1411-1420
15. Fang Y., Vilella-Bach M., Bachmann R., Flanigan A., and Chen J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294 (2001) 1942-1945
16. Veverka V., Crabbe T., Bird I., Lennie G., Muskett F.W., Taylor R.J., and Carr M.D. Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR. Oncogene 27 (2008) 585-595
17. Sarbassov D.D., Guertin D.A., Ali S.M., and Sabatini D.M. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 (2005) 1098-1101
18. Hui L., Abbas T., Pielak R.M., Joseph T., Bargonetti J., and Foster D.A. Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mol. Cell. Biol. 24 (2004) 5677-5686
19. Ashcroft M., and Vousden K.H. Regulation of p53 stability. Oncogene 18 (1999) 7637-7643
20. Freedman D.A., Wu L., and Levine A.J. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci. 55 (1999) 96-107
21. Momand J., Wu H.H., and Dasgupta G. MDM2-master regulator of the p53 tumor suppressor protein. Gene 242 (2000) 15-29
22. Ashcroft M., Ludwig R.L., Woods D.B., Copeland T.D., Weber H.O., MacRae E.J., and Vousden K.H. Phosphorylation of HDM2 by Akt. Oncogene 21 (2002) 1955-1962
23. Brazil D.P., Park J., and Hemmings B.A. PKB binding proteins. Getting in on the Akt. Cell 111 (2002) 293-303
24. Toschi A., Edelstein J., Rockwell P., Ohh M., and Foster D.A. HIFα expression in VHL-deficient renal cancer cells is dependent on phospholipase D. Oncogene 27 (2008) 2746-2753
25. Kulikov R., Boehme K.A., and Blattner C. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance. Mol. Cell. Biol. 25 (2005) 7170-7180
26. Mayo L.D., and Donner D.B. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus. Proc. Natl. Acad. Sci. USA 98 (2001) 11598-11603
27. Zhou B.P., Liao Y., Xia W., Zou Y., Spohn B., and Hung M.C. HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation. Nat. Cell Biol. 3 (2001) 973-982
28. Toschi A., Lee E., Gadir N., Ohh M., and Foster D.A. Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J. Biol. Chem. 283 (2008) 34495-34499
29. Garcia-Martinez J.M., and Alessi D.R. mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem. J. 416 (2008) 375-385
30. Amato R., D'Antona L., Porciatti G., Agosti V., Menniti M., Rinaldo C., Costa N., Bellacchio E., Mattarocci S., Fuiano G., Soddu S., Paggi M.G., Lang F., and Perrotti N. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J. Mol. Med. 87 (2009) 1221-1239
31. Lu M., Wang J., Jones K.T., Ives H.E., Feldman M.E., Yao L.J., Shokat K.M., Ashrafi K., and Pearce D. mTOR complex-2 activates ENaC by phosphorylating SGK1. J. Am. Soc. Nephrol. 21 (2010) 811-818
32. Lang F., Bohmer C., Palmada M., Seebohm G., Strutz-Seebohm N., and Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol. Rev. 86 (2006) 1151-1178
33. Loffing J., Flores S.Y., and Staub O. Sgk kinases and their role in epithelial transport. Annu. Rev. Physiol. 68 (2006) 461-490
34. Yan L., Mieulet V., and Lamb R.F. mTORC2 is the hydrophobic motif kinase for SGK1. Biochem. J. 416 (2008) e19-e21
35. Pearce L.R., Komander D., and Alessi D.R. The nuts and bolts of AGC protein kinases. Nat. Rev. Mol. Cell Biol. 11 (2010) 9-22
36. Amato R., Menniti M., Agosti V., Boito R., Costa N., Bond H.M., Barbieri V., Tagliaferri P., Venuta S., and Perrotti N. IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells. J. Mol. Med. 85 (2007) 707-721
37. Hong F., Larrea M.D., Doughty C., Kwiatkowski D.J., Squillace R., and Slingerland J.M. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol. Cell 30 (2008) 701-711
38. Nasir O., Wang K., Foller M., Gu S., Bhandaru M., Ackermann T.F., Boini K.M., Mack A., Klingel K., Amato R., Perrotti N., Kuhl D., Behrens J., Stournaras C., and Lang F. Relative resistance of SGK1 knockout mice against chemical carcinogenesis. IUBMB Life 61 (2009) 768-776
39. Vasudevan K.M., Barbie D.A., Davies M.A., Rabinovsky R., McNear C.J., Kim J.J., Hennessy B.T., Tseng H., Pochanard P., Kim S.Y., Dunn I.F., Schinzel A.C., Sandy P., Hoersch S., Sheng Q., Gupta P.B., Boehm J.S., Reiling J.H., Silver S., Lu Y., Stemke-Hale K., Dutta B., Joy C., Sahin A.A., Gonzalez-Angulo A.M., Lluch A., Rameh L.E., Jacks T., Root D.E., Lander E.S., Mills G.B., Hahn W.C., Sellers W.R., and Garraway L.A. AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer. Cancer Cell 16 (2009) 21-32
40. Toker A. mTOR and signaling in cancer: SGK cycles in. Mol. Cell 31 (2008) 6-8